NFE2L2 (NRF2) has been linked to glaucoma [81] and TGF-β2 [82] and may be a useful drug target to improve the outcome of glaucoma filtration surgery by reducing bleb fibrosis [83]. Here, NFE2L2 is linked to glaucoma.